- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00526565
Randomized Trial of Tapas Acupressure for Weight Loss Maintenance (LIFE)
October 4, 2011 updated by: Kaiser Permanente
This randomized clinical trial evaluates the efficacy of TAT(Tapas Acupressure Technique) compared to a Social Support (SS) group for the primary outcome of weight loss maintenance.
We recruit obese adults from the Kaiser Permanente Northwest managed care setting.
Those who meet eligibility criteria are entered into an intensive six-month weekly group-based behavioral weight loss program.
Those who meet threshold weight loss criteria (n=~288) are randomly assigned to either TAT instruction or social support group.
Participants in both groups attend the same schedule of group meetings with parallel contact hours.
Participants in the TAT group are advised to practice the technique at home.
Participants are weighed and questionnaires administered at entry, randomization, and at 12 and 18 months post entry.
The main outcome measure is weight at 18 months.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
472
Phase
- Phase 2
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 85 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria for the Phase I weight loss program:
- Men and women
- At least 30 years of age
- BMI 30-50 kg/m2 (inclusive)
- Weight <400 lbs
- Reside in Portland metropolitan area including Vancouver/Clark County, Washington
- Willing and able to participate in all aspects of the intervention
- Willing to attend the group-based weight loss program for 6 months
- Willing to follow a reduced calorie healthy dietary pattern
- Willing to exercise on a regular basis
- Willing to lose 10 pounds during the 6-month weight loss program
- Willing to accept random assignment to one of the two maintenance interventions
- Willing to provide informed consent
Exclusion criteria for the Phase I weight loss program
- Medical conditions or treatments that would be contraindicated using a diet and exercise weight loss treatment
- Treatment for cancer (except for non-melanoma skin cancer) currently or in the past 2 years
- Diabetes treated with insulin; does not exclude diet-controlled, controlled with sulfonylurea (glyburide, glipizide, etc.) with primary physician's approval, or controlled with other oral agents (metformin, precose, glitazone.)
- Psychiatric hospitalization in past 2 years
- Conditions that require limitation of physical activity
- Congestive heart failure
- Cardiovascular disease (stroke, MI, CABG, angioplasty/stent) in the past 2 years
- Taking weight loss medications currently or within past 6 months
- Any history of weight loss surgery or scheduled surgery for weight loss.
- Liposuction in the past 12 months
- Prior acupuncture or acupressure treatments for weight loss
- Planning to leave the area prior to the end of the program
- Body weight change > 20 pounds in the past 6 months
- Pregnant, breast feeding, or planning pregnancy prior to the end of participation
- Current participation in another clinical trial
- Investigator discretion for safety or adherence reasons
- Household member (living at the same address) of another participant in this study
- LIFE clinical trial staff member or family member of LIFE trial staff person
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: 1
TAT (Tapas Acupressure Technique)
|
Practice of the TAT technique involves application of pressure to select acupoints combined with specific mental focus.
The TAT pose involves lightly touching the tips of the left thumb and 4th finger to the area 1/8 inch above the inner corner of each eye and the 3rd finger to the point midway between the eyes, about ½ inch above eyebrow level.
The right hand is on the back of the head, with the palm cradling the occiput and the thumb just above the hairline.
Once in this position, the process is to 1) focus attention on the identified problem or behavior to be changed (e.g., over-eating); 2) focus on a positive thought related to the problem; 3) focus on the thought of healing or clearing the origins of the problem; and 4) focus on an awareness of healing or clearing any storage of the problem, at a cellular, mental, emotional, or energetic level.
Other Names:
|
ACTIVE_COMPARATOR: 2
SS (Professionally facilitated social support groups)
|
The LIFE SS maintenance intervention will consist of a series of professionally facilitated social support groups where the session content is directed by the participants.
The contact hours for SS will match those of the TAT intervention.
The initial SS group session will orient participants to the basics of weight maintenance, and subsequent sessions will provide opportunities for participants to share experiences and ask questions.
Participants may choose to use behavioral tools as desired.
In addition to the basic materials about weight loss maintenance used in both maintenance interventions, will we use the materials already used in the weight loss program for the SS group as needed.
We will measure adherence by taking attendance at the SS group sessions.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
weight
Time Frame: 18 months
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
psychosocial measures, exercise, food frequency, and food cravings variables
Time Frame: randomization, and @ months 12 and 18
|
randomization, and @ months 12 and 18
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Charles R Elder, MD, Kaiser Permanente
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (ACTUAL)
June 1, 2010
Study Completion (ACTUAL)
February 1, 2011
Study Registration Dates
First Submitted
September 6, 2007
First Submitted That Met QC Criteria
September 6, 2007
First Posted (ESTIMATE)
September 10, 2007
Study Record Updates
Last Update Posted (ESTIMATE)
October 5, 2011
Last Update Submitted That Met QC Criteria
October 4, 2011
Last Verified
October 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01AT003928-01A1 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Tapas Acupressure Technique
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSleep DisturbanceUnited States
-
Chang-Hua HospitalChina Medical University HospitalUnknownInsomnia | Anxiety | Menopause | Auricular AcupressureTaiwan
-
Mersin UniversityRecruiting
-
Mersin UniversityCompleted
-
Cairo UniversityCompleted
-
University of MichiganNational Cancer Institute (NCI)CompletedBreast Cancer | Sleepiness | Chronic FatigueUnited States
-
University of MichiganCompleted
-
China Medical University HospitalNot yet recruiting
-
Guangdong Provincial Hospital of Traditional Chinese...Completed